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Abstract 
This thesis examined protoplast proliferation and somatic embryogenesis, by 
comparing a highly with a poorly embryogenic Medicago truncatula line through 
microscopic, proteomic and in situ hybridization analysis. Proteome analysis of M. 
truncatula was used to identify proteins involved in protoplast proliferation and the 
initiation of somatic embryogenesis. Furthermore, an in situ hybridization study was 
done to compare the expression of genes known to be involved in zygotic 
embryogenesis with the expression during somatic embryogenesis. A large number 
of proteins were up-, and down-regulated during the first 5 days of protoplast culture 
indicating that cellular reorganization took place. An up-regUlation of PR 1 O-like 
proteins and flavonoid synthesis proteins and a down-regulation of energy 
metabolism proteins were observed, indicating an initiation of a stress response. The 
observed stress response in protoplasts was down-regulated before the first cell 
divisions at 5-7 d. A stress-inducing bioassay on protoplasts showed that the ability of 
protoplasts to overcome stress and to proliferate under stress conditions depended on 
the level of stress and density of the protoplast culture, whereby more stress or a 
lower culture density resulted in higher levels of cell death. Proteomic analysis of the 
initiation of somatic embryogenesis showed that similar metabolic pathways were 
involved in the initiation of somatic embryogenesis and protoplast proliferation. By 
using a highly embryogenic (2HA) line, and a poorly embryogenic (A 17) line of M. 
truncatu!a, it was shown that particular proteins were specifically accumulated 
during the initiation of somatic embryogenesis. A high accumulation of a peroxidase 
was observed only in At7 tissue at the time of initiation of somatic embryogenesis 
and might be the reason why the initiation of somatic embryogenesis is inhibited in 
A 17 tissue. The specific accumulation of flavonoid synthesis proteins might also 
indicate that flavonoids are involved during the initiation of somatic embryogenesis. 
In situ hybridization with probes to genes known to be involved in zygotic 
embryogenesis, showed that M. truncatula somatic and Arabidopsis thaliana zygotic 
embryogenesis both followed similar developmental pathways. However, a few 
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